This was the first Annual Review Molecular Insight Pharmaceuticals created. We explained their technology and focused on two theoretical case studies of patients helped by their products. Molecular imaging radiopharmaceuticals enable early detection of diseases such as heart attacks and prostate cancer. The annual describes the technology and business plan behind this organization.